THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series. “The U.S. now has access… read on > read on >



















